This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 3.74% to $599.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 3.20% to 3,991.24 and Dow Jones Industrial Average falling 1.99% to 32,245.70. This was the stock's third consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $147.65 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.54% to $177.33, Novartis AG ADR (NOVN.EB) fell 2.73% to $83.48, and Amgen Inc. (AMGN) rose 1.16% to $239.24. Trading volume (818,064) eclipsed its 50-day average volume of 648,090.
Data source: Dow Jones Market Data, FactSet. Data compiled May 9, 2022.
(END) Dow Jones Newswires
May 09, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.